Passage Bio lays off 26% of staff, lets two executives go a year after downsizing, leadership shuffle
Gene therapy biotech Passage Bio will let go about one-quarter of its workforce and is parting ways with two executives, nine months after a new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
